Skip to content
Industry inflectionsACBHITIROMJSNDLTLRYVFF

German Medical Cannabis Imports Split Between Premium and Converted Flower Pricing

Editorial illustration for German Medical Cannabis Imports Split Between Premium and Converted Flower Pricing
Published 6 min read

Summary

Village Farms and Rubicon say German import cannabis prices are splitting: at-source EU GMP and steady premium supply hold price while converted flower takes the cuts.

German medical cannabis import prices are splitting into two tiers, according to Village Farms International (VFF) and Rubicon Organics (ROMJ). On their Q3 2026 earnings calls, held between November 9 and 16, 2026, both companies said imported flower no longer sells at one price: sellers that can steadily supply compliant, premium product are holding price or seeing it firm, while most of the price cuts fall on other supply [1][2].


How German importers now separate supply

Germany and the UK rely mainly on imports for medical cannabis, and most sellers are Canadian and European growers. Flower entering these markets needs EU GMP certification, the European Union's good manufacturing practice standard for medicines. There are two ways to get it. A grower can produce under GMP conditions at the cultivation site itself, which is certification at source. Or flower can be grown outside GMP conditions and then processed by a certified processor that adds the certification later in the supply chain, which the industry calls conversion. Village Farms cited an analyst estimate that only about 57%, or roughly 420 tons, of the roughly 740 tons of EU GMP certified flower capacity worldwide is certified at source; the rest relies on conversion [1].

Early on, German importers mostly bought on THC content and price, wanting the highest THC at the lowest cost [2]. Two parts of that process are now changing. On the regulatory side, regulators in the UK and Germany, including the state government of Hesse, are tightening the conversion pathway [1]. On the buyer side, some importers are building their own brands and need about 100 kilograms of the same premium cultivar every month, while many Canadian contract growers can offer only 30 to 40 kilogram lots [2]. Both requirements push orders toward the few suppliers that can meet them.


Compliant and premium supply has not followed prices down

Village Farms management said German price compression has been most severe for converted product, that the company has not lowered its price on EU GMP product, and that this product still has a large backlog of demand behind it [1]. International exports rose 75% year over year to $20.8 million in the third quarter, and the company said it remains supply constrained [1]. In mid-October it also notified its partner that it was exercising a contractual right that allows it to convert 25% of its Delta-1 greenhouse to cannabis production during 2027, although it has no formal conversion plan today [1].

Rubicon Organics is a Vancouver-based grower of premium indoor cannabis. Its CEO said the market has seen price compression, driven mainly by distributors chasing volume, but the company is not seeing significant compression in its own market, and pricing has actually turned back toward the positive [2]. International sales were 11.7% of Rubicon's Q3 net revenue, and it has signed four export supply contracts [2]. The two companies draw the line in different places. Village Farms stresses certification at source; Rubicon stresses consistent premium volume. Rubicon itself is not EU GMP certified and ships its exports through a third-party EU GMP processor [3]. Certification method therefore explains only part of the split.


Pricing power may shift to growers that deliver compliant supply reliably

If regulators keep tightening the conversion pathway, pricing power in the import market could move toward growers with at-source certified capacity that can also deliver large premium lots month after month. Village Farms' supply-demand estimate is that Germany expects roughly 300 tons of imports this year and Australia, Israel and the UK more than 150 tons combined, against about 420 tons of at-source certified capacity; if conversion keeps being curtailed, compliant product could face shortages quickly [1]. Importers that depend on cheap converted supply could, in turn, see their sourcing channels narrow and their costs rise.

This view has clear limits. Tilray Brands (TLRY) sources about 90% of its international supply from its EU GMP site in Portugal, yet it still absorbed about $8.8 million of international price compression in fiscal Q1 2027 [4], so certification at source does not fully shield a seller from price pressure. When Germany will actually enforce the tighter rules is also uncertain. Indicators to track include Germany's formal rules on the conversion pathway and whether at-source certified sellers can sustain their export prices and volumes.


Which companies this change could affect

  • Aurora Cannabis (ACB): A Canadian cannabis exporter with most of its capacity in EU or Australian GMP certified facilities. Management has said German compression was concentrated in the value tier while core and premium pricing was unaffected, and it is acquiring an EU GMP certified grower to add at-source capacity [5]. If the conversion pathway tightens, Aurora sits on the compliant-supply side, but whether it benefits is unverified.
  • SNDL (SNDL): A Canadian cannabis producer whose Olds facility has passed an EU GMP audit. The company said exporting through a third-party processor had cost 20 to 45 cents a gram [6]. Its international flower business is moving from the tightened conversion route to at-source certification; whether its costs improve as a result still needs to be confirmed by later data.
  • High Tide (HITI): Its German importer Remexian buys Canadian cannabis on price and sold 10.2 tons for C$38.2 million in revenue in fiscal Q3 2026; management said German price compression was not touching it [7]. If the conversion channel narrows, Remexian's cheapest sourcing options could shrink and its input costs could rise.

Sources

[1] Drillr · Village Farms International (VFF) · 2026-11-09 · Q3 2026 earnings call

Many market participants have recently described price compression in Germany, particularly for converted product, meaning flour cultivated outside EU GMP conditions and certified later in the supply chain. UK and German regulators, including the Hassen government, are tightening requirements around these conversion pathways. A recent analyst estimates roughly 740 tons of EU GMP certified flour capabilities globally of which only about 57% or roughly 420 tons is EU GMP certified at the source of production. This balance relies on conversion and that's where pricing pressure has been most significant.

[2] Drillr · Rubicon Organics (ROMJ) · 2026-11-16 · Q3 2026 earnings call

[3] Drillr · Rubicon Organics (ROMJ) · 2026-05-14 · Q1 2026 earnings call

[4] Drillr · Tilray Brands (TLRY) · 2026-10-08 · Fiscal Q1 2027 earnings call

[5] Drillr · Aurora Cannabis (ACB) · 2026-06-11 · Fiscal Q4 2026 earnings call

[6] Drillr · SNDL (SNDL) · 2026-10-27 · Q3 2026 earnings call

[7] Drillr · High Tide (HITI) · 2026-09-15 · Fiscal Q3 2026 earnings call

This article highlights industry changes and companies that may be overlooked. It is not a stock recommendation.

Want deeper analysis?

Ask drillr anything about ACB, HITI, ROMJ, SNDL, TLRY, VFF — powered by SEC filings, earnings calls, and real-time data.

Try drillr.ai for free

drillr can make mistakes. Information only — not investment advice. Learn more